Liping Liu

8PUBLICATIONS
35CO-AUTHORS
Cardiovascular medicine and haematology not elsewhere classifiedMedical biochemistry - proteins and peptides (incl. medical proteomics)Elemental semiconductorsCancer diagnosisPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 20, 2026
Low-Dose Bevacizumab in HCC: Unresolved Questions on Hepatic Reserve, Cost Claims, and LRT Heterogeneity.

|Mar 24, 2026
Clinical Interpretation of Peri-ERCP Antibiotic Use in Distal Malignant Biliary Obstruction.

Jiajing Zhao, Liping Liu

|Feb 03, 2026
Beyond Genetic Enhancement: The Enhanced Steatosis Index Demands Risk-Stratified Thresholds and Subgroup-Specific Solutions.

Jiajing Zhao, Liping Liu

|Nov 08, 2024
CSTF2 Supports Hypoxia Tolerance in Hepatocellular Carcinoma by Enabling m6A Modification Evasion of PGK1 to Enhance Glycolysis.

Qiangnu Zhang, Yusen Zhang, Chuli Fu

|Jun 16, 2023
Hypoxia-Responsive lncRNA AC115619 Encodes a Micropeptide That Suppresses m6A Modifications and Hepatocellular Carcinoma Progression.

Qiangnu Zhang, Teng Wei, Lesen Yan

|Mar 18, 2023
Hypoxia-responsive PPARGC1A/BAMBI/ACSL5 axis promotes progression and resistance to lenvatinib in hepatocellular carcinoma.

Qiangnu Zhang, Lingfeng Xiong, Teng Wei

Pageof 2

Frequent Collaborators

2 joint publications

Meilong Wu

2 joint publications

Yusen Zhang

2 joint publications

Wen Jin

2 joint publications

Yu Bai